Published in Acta Paediatr Scand on January 01, 1978
Injury induces increase of von Willebrand factor in rat endothelial cells. Am J Pathol (1989) 1.03
Haemostatic defects in cyanotic congenital heart disease. Br Heart J (1979) 0.94
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med (1980) 4.03
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Reading the medical record. I. Analysis of physicians' ways of reading the medical record. Comput Methods Programs Biomed (1993) 2.60
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol (1997) 2.46
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology (1997) 2.29
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09
Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol (2002) 2.09
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial. Eur J Cancer (2006) 2.09
Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med (1985) 2.02
[Problems of interpretation in vascular surgery]. Lakartidningen (1993) 1.94
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst (2001) 1.90
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (2006) 1.84
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb (1991) 1.67
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
The impact of hormone replacement therapy on quality of life and willingness to pay. Br J Obstet Gynaecol (1997) 1.58
Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol (2002) 1.58
No association between fat and fatty acids intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.56
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol (1997) 1.51
Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer (2001) 1.49
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer (1999) 1.48
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int (1996) 1.45
Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis (1981) 1.43
Risk factors for male breast cancer--a case-control study from Scandinavia. Acta Oncol (2001) 1.40
Effects of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarction. Lancet (1988) 1.38
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br J Cancer (2001) 1.33
Purification of urokinase by affinity chromatography. Biochim Biophys Acta (1976) 1.32
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer (2003) 1.31
Two genetic variants of von Willebrand's disease. N Engl J Med (1973) 1.25
Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates. Br J Cancer (2011) 1.24
Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet (2000) 1.23
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest (1982) 1.23
A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med (1998) 1.22
Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. Br Med J (Clin Res Ed) (1986) 1.20
Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res (1999) 1.19
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med (1983) 1.18
Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med (1999) 1.18
Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall. Biochim Biophys Acta (1985) 1.18
Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature (1976) 1.17
Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control (1992) 1.17
Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat (1996) 1.16
Demands on surgical inpatient services after mass mammographic screening. Br Med J (Clin Res Ed) (1986) 1.15
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost (2006) 1.14
Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. Eur J Oncol Nurs (2004) 1.12
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study. Leukemia (2002) 1.11
Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol (1997) 1.10
The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Res (2001) 1.10
Maternal and infantile infection with Chlamydia in a Swedish population. Acta Paediatr Scand (1981) 1.10
Tetrasomy 15q: two marker chromosomes with no detectable alpha-satellite DNA. Am J Hum Genet (1994) 1.09
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort. Int J Cancer (2010) 1.08
Risk factors for local recurrence after breast-conserving surgery. Br J Surg (2003) 1.08
Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest (1985) 1.07
Protein C activity and antigen in premature and fullterm newborn infants. Acta Paediatr Scand (1989) 1.07
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group. Ann Chir Gynaecol (1998) 1.07
Long-term survival in 406 males with breast cancer. Br J Cancer (1985) 1.07
Hereditary X-linked thrombocytopenia maps to the same chromosomal region as the Wiskott-Aldrich syndrome. Blood (1988) 1.06
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int (2006) 1.06
Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women. Eur J Cancer (2002) 1.05
Estrogen therapy and liver function--metabolic effects of oral and parenteral administration. Prostate (1989) 1.05
Literature review of surgical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2001) 1.05
A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant (2003) 1.04
Genetic variants of von Willebrand's disease. Br Med J (1972) 1.03
Determinants of the psycho-social outcome after operation for breast cancer. Results of a prospective comparative interview study following mastectomy and breast conservation. Eur J Cancer (1992) 1.03
Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer (2009) 1.03
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF. Ann Oncol (2005) 1.02
Reading the medical record. II. Design of a human-computer interface for basic reading of computerized medical records. Comput Methods Programs Biomed (1993) 1.02
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia (2011) 1.02
An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta (1978) 1.02
Factor XIII (fibrin stabilising factor) in Henoch-Schönlein's purpura. Acta Paediatr Scand (1977) 1.02
An HphI-polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand's disease. Br J Haematol (1991) 1.02
Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol (1997) 1.02
Medicinal iron to low birth weight infants. Acta Paediatr Scand (1979) 1.02
Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. Scand J Haematol (1974) 1.02
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system. Bone Marrow Transplant (1998) 1.00
Biology and natural history of breast cancer. Int J Cancer Suppl (1990) 1.00
Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse: a randomized study. Scand J Urol Nephrol (2000) 0.99
The influence of mammography screening on the pathological panorama of breast cancer. APMIS (1997) 0.98
Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort. Cancer Res (2001) 0.96
Acquired cytomegalovirus infection. Br Med J (1968) 0.96
Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel. J Pediatr (1999) 0.96
The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. Br J Cancer (2008) 0.95
[Adverse effects of drugs in Sweden (I). Adverse effects with fatal outcome 1971-1975]. Lakartidningen (1977) 0.95
Haemostatic defects in cyanotic congenital heart disease. Br Heart J (1979) 0.94
Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. J Clin Invest (1989) 0.94